
CellaVision AB
STO:CEVI

Intrinsic Value
The intrinsic value of one
CEVI
stock under the Base Case scenario is
257.05
SEK.
Compared to the current market price of 195.6 SEK,
CellaVision AB
is
Undervalued by 24%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
CellaVision AB
Fundamental Analysis


Revenue & Expenses Breakdown
CellaVision AB
Balance Sheet Decomposition
CellaVision AB
Current Assets | 402.8m |
Cash & Short-Term Investments | 149.4m |
Receivables | 121.5m |
Other Current Assets | 131.9m |
Non-Current Assets | 610.2m |
Long-Term Investments | 2.7m |
PP&E | 119.9m |
Intangibles | 487.6m |
Free Cash Flow Analysis
CellaVision AB
SEK | |
Free Cash Flow | SEK |
Earnings Waterfall
CellaVision AB
Revenue
|
723.2m
SEK
|
Cost of Revenue
|
-236.1m
SEK
|
Gross Profit
|
487.1m
SEK
|
Operating Expenses
|
-309.4m
SEK
|
Operating Income
|
177.7m
SEK
|
Other Expenses
|
-37m
SEK
|
Net Income
|
140.7m
SEK
|
CEVI Profitability Score
Profitability Due Diligence
CellaVision AB's profitability score is 64/100. The higher the profitability score, the more profitable the company is.

Score
CellaVision AB's profitability score is 64/100. The higher the profitability score, the more profitable the company is.
CEVI Solvency Score
Solvency Due Diligence
CellaVision AB's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

Score
CellaVision AB's solvency score is 99/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CEVI Price Targets Summary
CellaVision AB
According to Wall Street analysts, the average 1-year price target for
CEVI
is 244.12 SEK
with a low forecast of 230.28 SEK and a high forecast of 262.5 SEK.
Dividends
Current shareholder yield for CEVI is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
CEVI
stock under the Base Case scenario is
257.05
SEK.
Compared to the current market price of 195.6 SEK,
CellaVision AB
is
Undervalued by 24%.